Archives of Clinical Neuropsychology
October 1, 2026
A. Purcell, Daniel L. Morris, Jahred Rosa-Sullivan et al.
Objective: Over the past 60 years, contemplative practices have been shown to alleviate certain mental health symptoms. Humans spend approximately one third of their lives asleep, yet there is limited scientific investigation of the benefit of performing contemplative exercises during sleep. Tibetan Buddhist Dream Yoga (TBDY) is a contemplative practice where dreamers perform mental exercises...
Archives of Clinical Neuropsychology
September 12, 2024
James Perry, Cara C. Young, Julie Williams
1 citation
Abstract Objectives The first line for symptom management of attention deficit hyperactivity disorder (ADHD) is a class of medications that act on dopamine and noradrenaline receptors, which leads to symptom reduction at the cost of significant side effects. These side effects have led to community searching for alternative methods that manage ADHD symptoms in adults that lead to less side...
Archives of Clinical Neuropsychology
October 20, 2023
Monica Y Garza Saenz, Beatriz MacDonald Wer, Sari Bar et al.
Abstract Objective This literature review examines the current understanding of mindfulness-based interventions (MBIs) as treatment for attention deficit hyperactivity disorder (ADHD) in children residing in United States (U.S), with a particular focus on research available for Latinx children. Data Selection A comprehensive literature search was conducted in February 2023 using four databases...
Archives of Clinical Neuropsychology
October 8, 2023
R. Hirst, Jakob Hopper, Dylan Vaughn et al.
OBJECTIVE Cannabis is one of the most widely used substances, and although the literature shows that it affects users' cognition, it is unclear how much that impact is affected by factors such as motivation. Previous studies utilizing validity measures showed that user motivation to perform well positively impacts California Verbal Learning Test - II performance, which was higher in cannabis...
Archives of Clinical Neuropsychology
August 17, 2022
Brian Peacock
3 citations
Abstract Objective: Psychedelic-assisted therapies are emerging as safe and effective treatments for some psychological conditions including depression, anxiety, posttraumatic stress disorder, and substance use disorders. As ketamine therapy is already available in general medicine and 3,4 Methylenedioxymethamphetamine (MDMA) and psilocybin are in late-stage clinical trials, neuropsychologists...
Archives of Clinical Neuropsychology
August 30, 2021
Maria E Dragulin, C. Jacova
To understand the role of trait mindfulness acting-with-awareness in the relationship between inhibitory control and ADHD symptom burden. We conducted a cross-sectional study with 103 adults, aged 18 to 86, mean age = 46, mean education = 15 years, 46% male. Participants were recruited in North Western Oregon counties. Eligible individuals were aged >18, fluent in English, and with normal...
Archives of Clinical Neuropsychology
September 22, 2018
Alexander L. Wallace, Natasha E Wade, Kelah Hatcher et al.
43 citations
OBJECTIVE: Research has demonstrated comorbidity between Attention-Deficit Hyperactivity Disorder (ADHD) and cannabis use, and some have proposed that subclinical ADHD symptoms may explain attentional deficits in cannabis users. Here we investigated whether subclinical ADHD symptoms and cannabis use independently or interactively predict performance on attention tasks in adolescents and young...
Archives of Clinical Neuropsychology
August 31, 2016
Michael Wagner, Michael C Mithoefer, Ann T Mithoefer et al.
1 citation
Objective: New data from a previously published randomized blinded Phase II clinical trial (Mithoefer, et al., 2011) is presented here to test whether psychological change mediates the effect of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment-resistant PTSD. Method: Twenty-three (23) subjects with treatment-refractory PTSD were randomized to either a...